Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/EJE-08-0881
European Journal of Endocrinology, Vol 160, Issue 3, 397-402
Copyright © 2009 by European Society of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
EJE-08-0881v1
160/3/397    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lapauw, B
Right arrow Articles by Ruige, J B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lapauw, B
Right arrow Articles by Ruige, J B

CLINICAL STUDY

Short-term aromatase inhibition: effects on glucose metabolism and serum leptin levels in young and elderly men

B Lapauw, G T'Sjoen, A Mahmoud, J M Kaufman and J B Ruige

Department of Endocrinology, 9K12 I.E., Ghent University Hospital, De Pintelaan 185, 9000 Ghent, Belgium

(Correspondence should be addressed to B Lapauw; Email: bruno.lapauw{at}ugent.be)

Objective: To assess and compare the effects of short-term aromatase inhibition on glucose metabolism, lipid profile, and adipocytokine levels in young and elderly men.

Design and methods: Ten elderly and nine young healthy men were randomized to receive letrozole 2.5 mg daily or placebo for 28 days in a crossover design.

Results: Both in young and elderly men, active treatment significantly increased serum testosterone (+128 and +99%, respectively) and decreased estradiol levels (–41 and –62%, respectively). Fasting glucose and insulin levels decreased in young men after active intervention (–7 and –37%, respectively) compared with placebo. Leptin levels fell markedly in both age groups (–24 and –25%, respectively), while adiponectin levels were not affected by the intervention. Lipid profile was slightly impaired in both groups, with increasing low density lipoprotein-cholesterol levels (+14%) in the younger age group and 10% lower levels of APOA1 in the elderly. A decline in IGF1 levels (–15%) was observed in the younger age group. No changes in weight or body mass index were observed in either young or old men.

Conclusions: Short-term aromatase inhibition appears to affect glucose metabolism in young men, and lipid metabolism, including leptin secretion, in young and elderly men. Furthermore, the short period of exposure suggests that these changes might be mediated by direct effects of sex steroids rather than by changes in body composition.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 European Society of Endocrinology.